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Women with epilepsy commonly have premature onset of menopause. The decrease
in estrogen levels is associated with increased occurrence of neurodegenerative
processes and cognitive decline. Previously, we found that estradiol (E2) replacement
in ovariectomized (OVX) female rats significantly reduced the seizure-related damage
in the sensitive hilar region of hippocampal dentate gyrus (DG). However, the complex
mechanisms by which E2 empowers the genomic fabrics of neurotransmission to
resist damaging effects of status epilepticus (SE) are still unclear. We determined the
protective effects of the estradiol replacement against kainic acid-induced SE-associated
transcriptomic alterations in the DG of OVX rats. Without E2 replacement, SE altered
expression of 44% of the DG genes. SE affected all major functional pathways, including
apoptosis (61%), Alzheimer’s disease (47%), cell cycle (59%), long-term potentiation
(62%), and depression (55%), as well as synaptic vesicle cycle (62%), glutamatergic
(53%), GABAergic (49%), cholinergic (52%), dopaminergic (55%), and serotonergic
(49%) neurotransmission. However, in rats with E2 replacement the percentage of
significantly affected genes after SE was reduced to the average 11% (from 8% for
apoptosis to 32% for GABAergic synapse). Interestingly, while SE down-regulated
most of the synaptic receptor genes in oil-injected females it had little effect on these
receptors after E2-replacement. Our novel Pathway Protection analysis indicated that
the E2-replacement prevented SE-related damage from 50% for GABA to 75% for
dopaminergic transmission. The 15% synergistic expression between genes involved
in estrogen signaling (ESG) and neurotransmission explains why low E2 levels result
in down-regulation of neurotransmission. Interestingly, in animals with E2-replacement,
SE switched 131 synergistically expressed ESG-neurotransmission gene pairs into
antagonistically expressed gene pairs. Thus, the ESG pathway acts like a buffer against
SE-induced alteration of neurotransmission that may contribute to the E2-mediated
maintenance of brain function after the SE injury in postmenopausal women. We also
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show that the long-term potentiation is lost in OVX rats following SE but not in those
with E2 replacement. The electrophysiological findings in OVX female rats with SE are
corroborated by the high percentage of long-term potentiation regulated genes (62%) in
oil-injected while only 13% of genes were regulated following SE in E2-replaced rats.
Keywords: beta-estradiol, cholinergic synapse, dentate gyrus, dopaminergic synapse, GABAergic synapse,
glutamatergic synapse, jun oncogene, serotonergic synapse
INTRODUCTION
Special considerations are necessary for women with epilepsy.
Irregularities in ovarian function (reflected in menstrual cycles),
may affect the likelihood of seizures (Harden et al., 1999;
Herzog et al., 2004; Velíšková and DeSantis, 2013). Especially
women with seizures originating in temporal lobe (temporal
lobe epilepsy, TLE) often have premature ovarian failure/early
menopause (late thirties-early forties), which may affect seizure
rate (Klein et al., 2001; Isojarvi, 2003; Pennell, 2009) and further
contribute to cognitive decline, dementia, and vulnerability
to neuronal dysfunction (Shuster et al., 2010; Rocca et al.,
2011). The female sex hormones (especially β-estradiol, E2)
have neuroprotective effects including attenuation of seizure-
induced hippocampal damage and cognitive decline. The E2
effects involve complex transcriptomic mechanisms that are still
poorly understood. Therefore, estrogen effects on seizures and
their consequences need to be further investigated to determine
beneficial effects of hormone therapy in women with epilepsy.
In this report, we analyze alterations in neurotransmission
transcriptome of the hippocampal dentate gyrus (DG) induced
by status epilepticus (SE) in ovariectomized (OVX) female rats
and compare to changes in OVX rats with E2 replacement.
In addition to the standard analyses based on our genomic
fabric paradigm approach (Iacobas et al., 2012, 2017; Iacobas,
2016), we used also novel quantifiers termed Weighted Pathway
Regulation (WPR) and Pathway Protection (PPR). The new
quantifiers are not affected by the arbitrarily introduced cut-
offs for the absolute fold-change and p-value to consider a
gene as significantly regulated. We focused on the interplay
between the estrogen signaling (ES) pathway and five types of
neurotransmission: glutamatergic (GLU), GABAergic (GABA),
dopaminergic (DA), cholinergic (ACH), and serotonergic (5HT).
Since estrogen acts through estrogen receptors, which are ligand-
induced transcription factors, we wanted to determine the extent
of its effects on gene transcription under condition of SE-induced
hippocampal damage.
Abbreviations: 5HT, Serotonergic synapse pathway; ACH, cholinergic synapse
pathway; ALZ, Alzheimer’s disease pathway; APO, apoptosis pathway; CC, cell
cycle pathway; CG, common genes; CUT, absolute fold-change cut-off to consider
a gene as regulated; DA, dopaminergic synapse pathway; DG, dentate gyrus; E2, β-
estradiol; ESG, estrogen signaling pathway; FC, fold-change; GABA, GABAergic
synapse pathway; GLU, glutamatergic synapse pathway; KA, kainic acid; LTD,
long-term depression pathway; LTP, long-term potentiation pathway; OVX,
ovariectomized; PPR, Pathway Protection; SE, status epilepticus; SVC, synaptic
vesicle cycle pathway; TBS, theta burst stimulation; TLE, temporal lobe epilepsy;
TPR, Transcriptomic Protection; WPR, Weighted Pathway Regulation
In order to understand the magnitude of the SE-related
damage and the protection provided by the E2 we have included
also data on several other pathways: apoptosis (APO), cell cycle
(CC), synaptic vesicle cycle (SVC), long-term potentiation (LTP),
long-term depression (LTD), and Alzheimer’s disease (ALZ).
Because estrogen signaling ESG and neurotransmission have
several genes in common, we considered these common genes
as the main vehicles through which ESG regulates the synaptic
connection and as such, the brain circuitry. The common genes
were identified using the Kyoto Encyclopedia of Genes and
Genomes developed by Kanehisa Laboratories (Kanehisa et al.,
2017). These genes are: adenylcyclases (Adcy2, Adcy3, Adcy5,
Adcy6, Adcy7, Adcy8, Adcy9), oncogenes (Akt1, Ak3, Fos, Hras,
Kras, raf1, Src), transcription factors (Atf4, Atf6b), calmodulins
(Calm1, Calm2, Calm3), membrane receptors (Gabbr1, Gabbr2,
Grm1, Itpr1, Itpr2), binding proteins (Creb1, Creb3l1, Gnai1,
Gnai2, Gnai3, Gnao1, Gnaq), ion channels (Kcnj3, Kcnj5, Kcnj9),
and kinases (Map2k1, Mapk1, Mapk3, Pik3ca, Pik3cb).
In addition, we show the complex transcriptomic regulation
of the hippocampal DG neurotransmission by E2 replacement
that is functionally important to preserve neuronal plasticity
following SE. Results bring essential insights into E2-
neurotransmission interactions, which are interesting beyond
the seizures for understanding sex-specific and hormonal
modulated depression/anxiety, stress processing, memory, and
cognition.
MATERIALS AND METHODS
Animals
Experiments were carried out according to the Revised
Guide for the Care and Use of Laboratory Animals and
approved by the New York Medical College Animal Care
and Use Committee. We used 8–9 week old female Sprague-
Dawley rats (Taconic Farms) kept on a 12-h light/dark cycle
(lights on at 07:00 a.m.) with food and water ad libitum.
Rats were OVX (=castrated) under ketamine/xylazine (70/10
mg/kg intraperitoneally) anesthesia and, 1 week later, injected
subcutaneously with either 17β-estradiol benzoate (2 µg/0.1
ml/day; Sigma-Aldrich, St. Louis, MO) or sterile peanut oil
(0.1ml; controls) daily at 10:00 for 4 consecutive days (Velíšková
and Velíšek, 2007), a treatment producing E2 levels within a
physiological range (Neal-Perry et al., 2005). Measurements of
vaginal impedance confirmed the successful OVX as well as
E2-replacement.
SE was induced by injection of kainic acid (12.5 mg/kg
intraperitoneally) 24 h following the last oil/E2 injection.
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Animals were observed for seizure occurrence and only animals
with at least2 h of continuous forelimb clonus seizures were
included for further experiments. There were no differences
in seizure severity or duration between the treatment groups
as described previously (Velíšková and Velíšek, 2007). SE was
terminated by diazepam (10 mg/kg i.p.) injection. Control
animals received saline as well as diazepam injections. Tissue
from all groups was collected 24 h after SE. As illustrated in
Figure 1A, studies were performed on four groups of OVX
female rats: CON (castrated, oil-injected, no SE), CEN (castrated,
E2-replaced, no SE), COS (castrated, oil-injected, SE), and
CES (castrated, E2-replaced, SE). CON and CEN animals were
obtained as previously described (Velíšková et al., 2015). All
rats were decapitated under light isoflurane anesthesia. Separate
groups of identically treated female rats were used for in vitro
electrophysiology experiments.
Electrophysiology in Vitro
After decapitation, the brains were removed. Transverse
combined entorhinal cortex-hippocampal slices (400µm thick)
were cut with a vibratome (Leica model DTK-1000) in ice-
cold artificial cerebrospinal fluid (aCSF; in mM: NaCl 126,
KCl 5, NaH2PO4 1.25, MgCl2 2, CaCl2 2, NaHCO3 26, and
glucose 10; pH 7.36). Recordings started following 1 h pre-
incubation in an interface chamber in a pre-warmed (34–
35◦C) and oxygenated (5% CO2/95% O2) aCSF. Field excitatory
postsynaptic potentials (fEPSPs) were recorded with a glass
microelectrode (2M NaCl; 2–5 M) placed in the middle third
of the DG molecular layer as described previously (Nebieridze
et al., 2012). Medial perforant path axons were stimulated once
each 30 s with a bipolar stainless-steel stimulating electrode (FHC
Inc.; Bowdoinham, ME). Baseline fEPSPs were recorded using a
stimulus intensity that produced ∼30% of maximal fEPSP slope.
FIGURE 1 | (A) Experimental design. OVX, ovariectomy; KA, kainic acid; saline, KA vehicle. Animals were injected with oil or 2 µg of β-estradiol benzoate for 4 days
subcutaneously. (B,E) Percentage of the regulated genes within the entire transcriptome (ALL) and included in the analyzed pathways in CES and COS groups with
respect to CEN, respectively CON groups. ALZ, Alzheimer’s disease, APO, apoptosis, CC, cell cycle, LTD, long-term depression, LTP, long-term potentiation, SVC,
synaptic vesicle cycle, GLU, glutamatergic synapse, GABA, GABAergic synapse, ACH, cholinergic synapse, DA, dopaminergic synapse, 5HT, serotonergic synapse.
Note the massive effect of SE on the gene expression. (C,F) WPR scores for selected pathways. In (B,C,E,F) lower is better (less damaging). (D,G) Protection against
transcriptomic regulation in E2-replaced animals quantified by both TPR (percent reduction of the number of significantly regulated genes) and PPR (percent reduction
of WPR). Note that DA had the largest (better) protection as quantified by PPR.
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FIGURE 2 | Power of the flexible fold-change cut-off. (A) Distribution of the fold-change cut-offs for the COS vs. CON comparison. COS, expression ratio in the
comparison COS vs. CON, CES, expression ratio in the comparison CES vs. CEN. When all 12,710 quantified unigenes are considered, CUT values range from 1.055
for Pcyt1a to 4.062 for Scgb1c1, with the average 1.451. (B) Distribution of the fold-change cut-offs for the CES vs. CEN comparison. When all 12,710 quantified
unigenes are considered, CUT values range from 1.109 for Mapk1ip1l to 3.877 for Ttr, with the average 1.633. (C) “False negatives” and “false positive” regulation hits
from the analyzed functional pathways. Note that expression ratio 2.226 was not enough for Chrna7 to be considered as up-regulated in COS vs. CON comparison
(CUT = 2.297) but 1.986 was enough in CES vs. CEN (CUT = 1.873).
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LTP was induced by theta burst stimulation (TBS; 10 bursts
delivered at interburst interval 200ms; each burst consisted
of 10 stimuli at 100Hz). The stimulus intensity has not been
changed during the TBS. Picrotoxin (50µM; Abcam, Cambridge,
MA, USA) was bath applied during the experiment to enhance
the LTP.
Microarray
Two hours after the onset of continuous seizures, under light
isoflurane anesthesia the rats were decapitated, brains were
removed and hippocampal DG were isolated. Four animals
were used from each of the four groups of OVX female rats
(CON, CEN, COS, and CES). Previously described experimental
protocol (Kravchick et al., 2016) was used for RNA extraction,
purification, fluorescent labeling and reverse transcription, and
hybridization with Agilent Rat GE 4 × 44k v3 microarrays in
the “multiple yellow” design (Iacobas et al., 2006). In this design,
differently labeled biological replicates are co-hybridized with
each microarray. A non-control microarray spot is valid if the
foreground fluorescence is at least twice its background. We
normalize the background-subtracted fluorescence of each valid
spot to the median of all same-label valid spots in the array, and
compute the average for all spots probing the same transcript
(thus eliminating the array redundancy). Same label average
values for each transcript are then compared across experimental
conditions and results averaged for the two colors. An in-house
developed iterative algorithm renormalizes all data sets across the
fluorescent labels and experimental conditions until the average
change of expression ratios between successive iterations falls
below 5%.
Functional Pathways
We used Kyoto Encyclopedia of Genes and Genomes (KEGG)
maps developed by Kanehisa Laboratories (Kanehisa et al., 2017)
to select the genes responsible for estrogen signaling pathway
(map04915) and for cholinergic (map04725), glutamatergic
(map04724), GABAergic (map04727), dopaminergic
(map04728), and serotonergic (map04726) transmissions.
KEGG maps were also used for apoptosis (map04210), cell
cycle (map04110), synaptic vesicle cycle (map04721), long-term
potentiation (map04720), long-term depression (map04730),
and Alzheimer’s disease (map05010) pathways. Although KEGG
designed map04730 for the cerebellar long-term depression the
basic molecular mechanisms are likely to occur also in the DG.
Data Analysis
According to our laboratory standard (Lee et al., 2017), a gene
was considered as regulated (here by SE in oil-injected/E2-
replaced females with respect to the corresponding non-SE
animals) if the absolute fold-change (FC) exceeded the combined
contributions of the technical noise and biological variability
(CUT, cut-off). The regulation was considered significant if
the p-value of the heteroscedastic t-test of the equality of the
average expression levels in the compared conditions with the
Bonferroni-type correction for redundant spots probing the same
gene (Iacobas et al., 2005) was below 0.05. This FC cut-off
TABLE 1 | Genes turned on/off by E2 replacement alone (in non-SE rats) and
genes turned on by SE (in COS animals) but prevented by E2 replacement (CES
rats).
Gene Symbol
Genes turned on by estradiol replacement alone
Chemokine (C-C motif) receptor 10 Ccr10
Fibronectin type III domain containing 5 Fndc5
G protein-coupled receptor 39 Gpr39
Short coiled-coil protein Scoc
Unc-5 homolog C (C. elegans) Unc5c
Genes turned off by estradiol replacement alone
Leukocyte cell derived chemotaxin 1 Lect1
Genes whose turned on by se was prevented by estradiol
replacement
ARP1 actin-related protein 1 homolog B (yeast) Actr1b
A disintegrin and metalloprotease domain 4 Adam4
ArfGAP with GTPase domain, ankyrin repeat, and PH domain 1 Agap1
Adenosylhomocysteinase-like 1 Ahcyl1
Aldehyde dehydrogenase family 1, subfamily A7 Aldh1a7
Amyotrophic lateral sclerosis 2 (juvenile) homolog (human) Als2
ATPase, H+ transporting, lysosomal V0 subunit A2 Atp6v0a2
Dopamine receptor D2 Drd2
Family with sequence similarity 53, member B Fam53b
Forkhead box C2 Foxc2
Gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) Gnrh1
HECT, C2 and WW domain containing E3 ubiquitin protein
ligase 2
Hecw2
Helicase, lymphoid specific Hells
Hepatocyte growth factor Hgf
Minichromosome maintenance complex component 4 Mcm4
Myelin gene regulatory factor Mrf
Myosin, heavy chain 10, non-muscle Myh10
Nuclear transcription factor-Y alpha Nfya
Patatin-like phospholipase domain containing 3 Pnpla3
Surfactant protein C Sftpc
Sarcoglycan zeta Sgcz
Seven in absentia 1A Siah1a
SLAM family member 8 Slamf8
Solute carrier family 39 (zinc transporter), member 14 Slc39a14
Syntaxin 2 Stx2
SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) Sumo3
Transcription factor AP-2 beta Tcfap2b
Tetratricopeptide repeat domain 33 Ttc33
Ubiquitin-associated protein 2 Ubap2
Unc-5 homolog D (C. elegans) Unc5d
Zinc finger, C4H2 domain containing Zc4h2
Zinc metallopeptidase, STE24 homolog (S. cerevisiae) Zmpste24
Zinc finger, MYM-type 4 Zmym4
Zinc finger protein 286A Znf286a
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computed for every single gene includes in the regulated list the
“false negatives” of the traditionally uniform 1.5 × (very stably
expressed genes across biological replicates that are probed by
very clean spots with 1.5> FC> CUT). In addition, it eliminates
most of the “false positives” from the variably expressed genes
that are also probed by not so clean spots (1.5< FC< CUT).
FIGURE 3 | Electrophysiology and transcriptomics of the long-term potentiation (LTP). (A,B) Medial perforant path LTP in the DG in OVX rats is lost following SE but
preserved in E2-replaced animals. LTP induced by TBS following SE (filled circles) compared to rats with no seizures (open circles). An arrow marks a moment when
the TBS was administered. In slices from oil-injected rats exposed to SE (COS; n = 5), TBS-induced LTP was severely reduced compared to LTP from rats with no SE
(CON; n = 10). In contrast, the magnitude of TBS-induced LTP in slices from E2-replaced OVX rats following SE (CES; n = 5) was not different from LTP in slices from
rats with no seizure experience (CEN; n = 10). (C,D) Dramatic regulation of LTP associated genes by SE in OVX rats compared to their non-SE counterparts (COS vs.
CON) is in contrast to protection against the transcriptomic regulation of LTP associated genes in E2 replaced animals (CES vs. CEN). As specified in the “COLOR
CODE” inset table, red/green/yellow background of the gene symbol indicates up-/down-/no regulation, while the white background indicates that expression of that
gene was not quantified. Note the significantly lower number of regulated genes in rats with E2 replacement.
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In addition to the percentages of up-/down-regulated genes,
we have also computed theWeighted Pathway Regulation (WPR)
and Pathway Protection (PPR, similar to Pathway Restoration
Efficiency) that we have recently introduced (Iacobas et al.,
2017). WPR and PPR are free of the arbitrary FC and p-
value cut-offs to consider a gene as significantly regulated and
take also into account the magnitude and significance of each
gene regulation. Thus, a gene with 2 × fold-change at p-
val = 0.01 contributes to WPR more than twice than a gene
with 1.5 × fold-change at p-val = 0.05. This approach is
different from the percentage of regulated genes that not only
depends on the arbitrarily introduced cut-offs but treats all
FIGURE 4 | Regulation of the glutamatergic synapse pathway by SE in OVX rats with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts
(CEN and CON). Note the large number of down-regulated genes by SE in oil injected rats [e.g., metabotropic glutamate receptor 3, Grm3 in (A)] whose expression
was not affected by SE in rats with E2 replacement (B).
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regulated genes as equal contributors. We have used also the
Transcriptomic Protection (TPR), similar to the Transcriptomic
Recovery Efficacy (Lachtermacher et al., 2011; Soares et al., 2011),
representing the reduction of the percentage of regulated genes
while considering also the side effects (i.e., the percentage of the
regulated genes by the E2-replacement alone).
FIGURE 5 | Regulation of the GABAergic synapse pathway by SE in OVX rats with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts
(CEN and CON). Note large number of genes down-regulated by SE in oil-injected animals [e.g., GABA B receptor 1, Gabbr1 in (A)] whose expression was not
affected by SE in rats with E2 replacement (B).
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Transcriptomic Networks
For each condition (CON, COS, CEN, CES) we determined how
much expression of each gene is coordinated with expression
of each other gene by computing Pearson correlation coefficient
between the expression levels of the two genes among biological
replicates. Expression coordination of two genes may result
from several molecular mechanisms that may include (but it
is not restricted to) the regulation of the expressions of both
genes by a common transcription factor. We used coordination
analysis (Iacobas et al., 2007a; Iacobas and Iacobas, 2010) to
determine the transcriptomic networks by which genes in the
estrogen signaling pathway controls the genes involved in all
FIGURE 6 | Regulation of the dopaminergic synapse pathway by SE in OVX rats with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts
(CEN and CON). Note the number of genes down-regulated by SE in oil-injected animals [e.g., DOPA decarboxylase, Ddc in (A)] whose expression was not affected
by SE in rats with E2 replacement (B).
Frontiers in Neuroscience | www.frontiersin.org 9 June 2018 | Volume 12 | Article 332
Iacobas et al. Estrogen Protects Neurotransmission in Epilepsy
types of neurotransmission in the female DG. The analysis
is based on our principle of “transcriptomic stoichiometry”
(Iacobas et al., 2007b; Iacobas, 2016) stating that genes whose
encoded proteins are working together in functional pathways
should be coordinately expressed to produce the pathway
players in the right proportions. In a previous paper (Iacobas
et al., 2007c), we have shown that the transcriptomic networks
do not stop at the cellular border. Instead, they may cross
it to link pathways from (phenotypically similar or distinct)
neighboring cells via intercellular signaling (Iacobas et al.,
2006d).
RESULTS
We quantified expressions of 12,710 distinct genes in all
16 samples and computed 80,765,695 Pearson correlation
coefficients among these genes for each of the four conditions.
Detailed experimental procedure and raw and normalized gene
FIGURE 7 | Regulation of the cholinergic synapse pathway by SE in OVX rats with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts
(CEN and CON). Again, note the large number of genes down-regulated by SE in oil-injected animals [e.g., acetylcholinesterase, Ache in (A)] whose expression was
not affected by SE in rats with E2 replacement (B).
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expression data are publically available at http://www.ncbi.nlm.
nih.gov/geo as GSE60013 and GSE107725.
Gene Expression Regulation by SE and
Protection by E2 Replacement
Figures 1B,E present the percentage of the SE-related regulated
genes from all analyzed pathways in COS and CES groups
with respect to their corresponding controls (CON and CEN
groups). Of note is the substantial reduction of the percentage of
regulated genes in OVX rats with EB replacement compared to
the animals that received only oil. Note that larger percentages
of genes were altered synaptic pathways than the overall
alteration percentage in the entire transcriptome. Figures 1C,F
present the WPR scores for selected pathways, confirming the
FIGURE 8 | Regulation of the serotonergic synapse pathway by SE in OVX with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts (CEN
and CON). Note the number of down-regulated genes by SE in oil-injected animals [e.g. serotonin receptor 5B, Htr5b in (A)] whose expression was not affected by SE
in rats with E2 replacement (B).
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substantially lower alteration of these pathways in rats with E2
replacement. Figures 1D,G present the protection against SE
alteration in E2 replaced animals as quantified by both TPR
and PPR.
The expression ratios (x, negative for down-regulation),
the absolute fold-change cut-offs (CUT) and the p-values for
all regulated genes in the analyzed pathways are listed in
the Supplementary Table S1. In order to illustrate how our
method of flexible FC cut-off works, we present in Figure 2 the
distributions of the FC cut-offs and the list of “false negatives”
(e.g., Abl1 with 1.5 > COS = 1.477 > CUT = 1.298) and
“false positives” (e.g., Chrna7 with 1.5 < COS = 2.226 <
CUT = 2.297) selected from the Supplementary Table S1. Of
note from Figure 1C is that the FC ranges from 1.104 (for the
“false negative” Cdc16 in COS) to 2.821 (for Raf1 in CES).
In addition to regulate the expression of thousands genes, both
SE and E2 replacement separately or together turned ON/OFF
many other genes. Table 1 lists the turned on/off genes by E2
replacement alone in non-SE rats and the genes whose turning
on by SE was prevented by E2 replacement.
Effects of SE on the LTP in the
Hippocampal DG of OVX Oil-Injected and
E2 Replaced Female Rats
To confirm the functional protection provided by the E2
replacement against SE, we compared the TBS-induced LTP in
the hippocampal DG of animals with no SE experience to LTP
from animals following kainic acid-induced SE. In oil-injected
OVX females (no E2 replacement), we found that the TBS-
induced LTP was lost following SE (Figure 3A) while in OVX
FIGURE 9 | Regulation of the synaptic vesicle cycle pathway by SE in OVX with (CES)/without (COS) E2-replacement with respect to their non-SE counterparts (CEN
and CON). Note that in oil-injected animals (A) the vesicle cycle was altered by SE in all phases but only few genes were affected in animals with E2 replacement (B).
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rats with E2 replacement, the magnitude of the TBS-induced
LTP in the DG was not affected by SE (Figure 3B). These data
are in accord with the transcriptomic findings (Figures 3C,D).
Thus, the LTP data clearly demonstrate that the DG plasticity was
functionally severely compromised and associated with dramatic
gene regulation in the LTP pathway following SE in OVX
animals. In contrast, the SE did not disturb the LTP in animals
with E2 replacement.
Regulation of Neurotransmission
Pathways by SE w/o E2 Replacement
Figures 4–8 present the regulation of GLU, GABA, DA, ACH,
and 5HT pathways by SE in OVX rats w/o E2-replaced with
respect to their non-SE counterparts. Of note is the large number
(58!) of down-regulated genes in oil-injected animals whose
expression was preserved in E2-replaced rats. The protected
genes include: adenylate cyclases (Adcy2, Adcy5), calcium
(Cacna1a, Cacna1b, Cacna1c), potassium (Kcnd2, Kcnj14), and
solute carrier (Slc12a5, Slc17a7, Slc1a3, Slc1a6, Slc6a1, Slc6a13)
channels and kinases (Camk2a, Camk2b, Camk4, Mapk10,
Pik33r2, Prkcb, Prkcg). E2 replacement preserved also expression
of several receptor genes: Chrm4, Gabr1, Gabr5, Gabrd, Gnal,
Gnao1, Gng3, Gng4, Gria1, Gria2, Gria4, Grik4, Grik5, Grin2a,
Grin2d, Grm1, Grm3, Htr5b, Htr7, Itpr1). Moreover, the down-
regulation of Gria3 in oil-treated animals was switched to
up-regulation in E2-replaced. E2 replacement also protected
some binding proteins (Gnb4, Gng10, Gng11, Gng12, Gng5)
and oncogenes (Akt3, Fos, Jun, Raf1) against the SE-related
upregulation. However, other genes, not affected by SE in oil-
injected animals were regulated in E2-replaced ones (Adcy7,
Chrm3, Gabarapl1, Gabra4, Gabrq, Gnb1, Grik1, Gsk3b, Homer1,
Kcnj3, Ppp2r2b, Shank2, Slc1a2, Sos2). The protection against
SE-related down-regulation of Itpr1 and calcium channels is
particularly important for the role these genes play in the
intercellular calcium signaling (Iacobas et al., 2006d).
Our data show (Figure 9) that also the synaptic vesicle cycle
(SVC) was massively altered by SE in oil-injected females and on
much smaller scale in rats with E2 replacement.
SE Remodels the Transcriptomic Networks
by Which the ESG Pathway Controls
Neurotransmission
We found that SE not only regulates the ESG pathway
(Figure 10) but also profoundly remodeled the transcriptomic
networks by which ESG regulates neurotransmission.
Interestingly, in animals with E2 replacement, SE turned
FIGURE 10 | Regulation of the estrogen signaling pathway by SE in OVX females with E2 replacement. Note that, in addition to up-regulating Adcy7, Adcy8, Creb1,
Creb3l1, Gnai1, Gnai3, Kcnj3, Kras, Prkacb, and Sp1, SE turned on Calml3, Itpr3, Mmp9, Pik3r1, and Pik3r3. No gene of this pathway was found as down-regulated
or turned off by SE.
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on the very important Pik3r1 and Pik3r3 [phosphoinositide-
3-kinase regulatory subunits 1 (alpha) and 3 (gamma)]
that control numerous major pathways via the PI3K-AKT
signaling.
Figures 11A and 12A present the transcriptomic networks
that interlink ESG pathway genes with glutamatergic and
cholinergic transmission via common genes in OVX animals
with E2 replacement. Figures 11B, 12B show how SE altered
these networks. The analysis revealed high degree (15%) of
synergistic expression between genes involved in ESG pathway
and all types of neurotransmission. This synergism means that
when the ESG diminishes, the expression of neurotransmission
genes decreases as well. This may explain why decline in E2
levels is associated with increased incidence of neurodegenerative
diseases.
FIGURE 11 | The transcriptomic networks by which the estrogen-signaling
(ESG) pathway genes regulate the glutamatergic synapse (GLU) genes
through expression coordination with the common genes (CG) between the
two pathways in OVX rats with E2-replacement. (A) Networks in the DG of
non-SE animals. A red/blue line indicates that the linked genes are significantly
(p-value < 0.05) synergistically/antagonistically expressed, respectively.
Numbers on the left side represent the percentages of the synergistically
(S)/antagonistically (A)/independently (I) expressed pairs that can be formed
between the two groups of genes. (B) Networks in the DG of SE animals.
Red/green/yellow background of the gene symbol indicates that that gene
was up-/down-/not regulated by SE. Note that there is a substantial shift from
synergistic to antagonistic expression between ESG and CG groups in SE
animals.
We also noticed that in animals with E2 replacement
the synergistic expression of 131 ESG-neurotransmission
gene pairs was switched by SE into antagonistic expression
(albeit 25 pairs were switched from antagonistically to
synergistically expressed). Thus, when expression of the
ESG gene partner decreases, the expression of the paired
neurotransmission gene goes up, likely compensating for the
decrease of other synapse molecular factors. Figure 13 presents
the ESG-neurotransmission gene pairs that switched their
expression coordination from synergistic to antagonistic or
vice versa in E2-replaced animals following SE. For instance,
the transcription factor Jun, known for its role in synaptic
plasticity and term memory formation (Alberini, 2009) had
13 synergistic-to-antagonistic switch(with: Arrb2, Ddc, Dlg4,
Gabra1, Gabra2, Gabr4, Gabrg2, Gng2, Gria2, Gria3, Grik5,
FIGURE 12 | The transcriptomic networks by which the estrogen-signaling
(ESG) pathway genes regulate the cholinergic synapse (ACH) genes through
expression coordination with the common genes (CG) between the two
pathways in OVX rats with E2-replacement. (A) Networks in the DG of non-SE
animals. (B) Networks in the DG of SE animals. Note the substantial shift from
synergistic to antagonistic expression between ESG and CG groups in SE
animals.
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FIGURE 13 | ES-neurotransmission gene pairs that switched their expression coordination from synergistic to antagonistic (white to blue bullets) or from antagonistic
to synergistic (white to red bullets) following SE.
Grm3, Gsk3a) and 2 antagonistic-to synergistic ones (Casp3,
Cyp2j3).
It is interesting how the expression coordination of Jun with
major synapse membrane receptors depends on the E2 presence
and changes following SE. As illustrated in Figure 14, the E2-
replacement doubled the number of synergistically expressed
partners for Jun among the synaptic receptors and turned
Gabra1 from an independently to a synergistically expressed
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FIGURE 14 | Expression correlation of Jun oncogene with some synapse membrane receptors in the DG of OVX rat female rats. (A) Oil-injected, non-SE rats;
(B) Oil-injected SE rats; (C) E2-replaced, non-SE rats; (D) E2-replaced, SE rats. A continuous red/blue line indicates significant (P-value < 0.05) expression
synergism/antagonism of Jun with the linked gene, an interrupted black line indicates significant (p-value < 0.05) expression independence, while missing lines mean
that we have not enough evidence to categorize the expression coordination of Jun with that gene.
gene. In both oil-injected and E2-replaced animals, SE induced
antagonistic expression of Jun with several synaptic receptors.
DISCUSSION
We show that the well-known neuroprotective effects of
E2, in this case against SE-induced hippocampal damage,
involve complex, multifactorial changes including alteration of
neurotransmission pathways. Our study stresses the importance
of considering global genomic changes when studying effects
of steroid hormones. The neuroprotective effects of E2
against SE-induced damage involve widespread regulation of
neurotransmitter systems. Our data further shows that loss
of estrogen leads to a state of transcriptomic instability,
which may significantly contribute to neuronal vulnerability
and, consequently, may render the system more susceptible
to neurodegenerative processes. We identified a large number
of down-regulated genes in the neurotransmission pathways
induced by SE in oil-injected females and interpreted this
finding as the major culprit for most of SE features. Indeed,
E2 replacement led to restoration of the expression of many of
these genes and we consider this as a good indication of the E2
protective role of brain circuitry.
The overall technical noise of the arrays hybridized with
samples from oil-injected animals is practically equal to that of
the samples from E2-replaced animals as indicated by comparing
the control spots. Hence, the lower average (and median) of the
FC distribution in the COS vs CON results from the reduction of
expression variability in the compared conditions. This result is
consistent with our robust finding in hundreds of transcriptomic
experiments that the expression variability is larger in tissues
of animals closer to their normal condition than in disease
conditions. As presented in a previous publication (Iacobas,
2016) CES and CEN are closer to the conditions of intact females
with/without SE than are COS and CEN.
The coordination analysis of the over 80 mil gene pairs in each
condition, sorted in numerous interplays among the genomic
fabrics of functional pathways provides an enormous amount
of information. Complete presentation of this information is
not possible to cover in a single report. Therefore, we have
selected some results that may enhance our understanding of
the complex molecular mechanisms triggered by the SE and the
neuroprotective role of E2 replacement on brain circuitry.
Frontiers in Neuroscience | www.frontiersin.org 16 June 2018 | Volume 12 | Article 332
Iacobas et al. Estrogen Protects Neurotransmission in Epilepsy
Studies in patients with epilepsy suggest that particularly
in the DG, seizure-induced hippocampal damage (sclerosis)
is associated with memory deficits (Helmstaedter et al., 1997;
Grunwald et al., 1999a,b). Recordings from resected human
hippocampal specimens indicate that in patients with temporal
lobe epilepsy (TLE) that was associated with hippocampal
sclerosis, TBS-induced LTP in the DG is lost (Beck et al., 2000).
Our present data show that following kainic acid-induced SE,
a model of seizures originating in the temporal lobe (Velíšková
et al., 2000; Velíšková and Velíšek, 2007), TBS-induced LTP
is severely impaired in slices from oil-injected, but not E2-
replaced OVX rats. Interestingly, anMRI study has demonstrated
that young women are less likely to develop TLE-associated
hippocampal damage suggesting possible protective effects of
female ovarian hormones (Briellmann et al., 2000). Indeed,
our previous studies showed that kainic-acid-induced SE was
associated with severe neuronal loss in the vulnerable hilar
region of the DG in OVX rats but the neuronal damage was
significantly ameliorated in E2-replaced animals (Velíšková et al.,
2000; Velíšková and Velíšek, 2007). We would like to emphasize
that in OVX rats, the dose of E2 used in our studies produces
circulating levels of E2 within the physiological range (Neal-
Perry et al., 2005). This E2 dose is not only neuroprotective
against the SE-induced hippocampal damage but it also has
a mild anticonvulsant effect (Velíšková et al., 2000; Velíšková
and Velíšek, 2007). Others have used various doses of E2
and showed consistent neuroprotective effects against seizure-
induced hippocampal neuronal damage regardless the E2 dose
but the supraphysiological E2 levels were associated with a
proconvulsant effect (see Velíšková and DeSantis, 2013 for
detailed review).
Very important findings of this study concern Jun
oncogene (Jun) expression regulation and coordination
with neurotransmission genes. As part of the activator protein-1
(AP-1), Jun is involved in major cellular processes including
differentiation, proliferation and cell survival, frequently leading
to cancerous processes, (Papoudou-Bai et al., 2017; Shrihari,
2017; Tewari et al., 2017). Significant up-regulation of Jun by
SE in oil-injected rats (2.9x) can explain vast occurrence of
SE-related brain damage through activation of pro-apoptotic
genes (Kravchick et al., 2016). Importantly, expression of Jun
was not altered by SE in E2-replaced animals, proving again the
important protection E2 provides to the brain likely through its
interference with apoptotic process here represented by Jun.
In a recent study (Iacobas et al., 2018) on a rat model of
infantile spasms, we have analyzed how the epileptic spasms
alter the neurotransmission in the hypothalamic arcuate nucleus
and how the ACTH or PMX53 (a potent complement C5ar1
antagonist) treatment recovers most of these alterations. Thus,
the question exists whether initiation of the E2 replacement
in adult OVX females following the SE would also rescue the
deteriorating effects of SE.
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